Monkeypox medication not authorised in Switzerland
The antiviral drug tecovirimat and the latest generation smallpox vaccine – which both help against monkeypox and are authorised in the European Union – are not available in Switzerland, the NZZ am Sonntag newspaper has reported.
This content was published on
3 minutes
NZZ am Sonntag/SonntagsBlick/WHO/SWI/ilj
Español
es
El medicamento contra la viruela del mono no está autorizado en Suiza
The news comes after Switzerland confirmed its first case of monkeypox, in canton Bern, on Saturday evening.
Tecovirimat is usually administered in severe cases. But as is highlighted in the NZZ am SonntagExternal link article – and on the Federal Office of Public Health (FOPH)’s special monkeypox infopageExternal link – this treatment is not currently authorised in Switzerland.
Also not authorised is the third-generation smallpox vaccine, which provides good protection against monkeypox. There is no specific vaccine against monkeypox.
The Swiss Agency for Therapeutic Products Swissmedic told the NZZ am Sonntag that it had not received any applications for this vaccine in recent years. Smallpox, which is closely related to monkeypox, was considered eradicated, which is why pharma firms had not made applications, it said.
More details have emerged over the first case. According to SonntagsBlickExternal link, the person concerned is a middle-aged man who has light symptoms and is in isolation at home.
Officials: risk ‘low’
“We currently assess the risk as low, but epidemiological data is still limited,” the FOPH’s Céline Gardiol told Swiss public television SRF on SundayExternal link. “However, it can be assumed that more cases could occur in our country, as is the case in other countries,” said the head of the vaccine recommendations and control measures section.
The monkeypox virus is considered to be moderately transmissible to humans and the disease is usually mild. It is important that people with symptoms – these include fever, headache and a rash that develops pustules – see a doctor quickly, said Gardiol.
The Swiss health authorities are currently observing the situation and are in contact with international health authorities and experts, added FOPH deputy director Linda Nartey.
“At the moment we have no evidence that we are facing a new pandemic,” said Nartey on SRF. “But the situation – as being done already – needs to be monitored.”
WHO concerns
Meanwhile, the Geneva-based World Health Organization (WHO), said late Saturday evening that there had been 92 laboratory confirmed cases and 28 suspected cases in 12 WHO member countries which are not endemic for the monkeypox virus. The virus is normally found in parts of West and Central Africa.
The WHO warned that it expected more cases of monkeypox as surveillance expands in non-endemic countries.
Popular Stories
More
Culture
Documentary portrays Swiss teenagers forced to return to parents’ homeland
Switzerland condemned for deciding to deport gay Iranian
This content was published on
Switzerland violated the prohibition on inhuman treatment by considering that a gay Iranian could be returned to his country.
Gestational diabetes found to increase risk of adult-onset diabetes
This content was published on
A research team from the Lake Geneva region has identified persistent dysfunctions in glucose regulation in women with gestational diabetes. In the long term, this can increase the risk of adult-onset diabetes by up to ten times.
Swiss village must be evacuated by midday on Sunday
This content was published on
The village of Brienz-Brinzauls in eastern Switzerland, which is threatened by a rockfall, must be evacuated by 1pm on Sunday. All residents must leave the village.
This content was published on
A former judge of the Graubünden Administrative Court in eastern Switzerland has been found guilty of rape, sexual harassment and threatening a former trainee.
Costs and care time increase in Swiss retirement and nursing homes
This content was published on
In 2023 the costs of retirement and nursing homes increased by 5% compared to 2022 and those of assistance and care at home by 7%. Together, they amounted to CHF15 billion.
This content was published on
Almost half of the population in Switzerland shows clear to pronounced signs of smartphone addiction, according to a survey.
Swiss healthcare stakeholders want to save CHF300 million
This content was published on
The main players in the Swiss healthcare sector want to save around CHF300 million ($340 million) in healthcare costs a year from 2026.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.